ANITA DESWAL to Cardiotoxicity
This is a "connection" page, showing publications ANITA DESWAL has written about Cardiotoxicity.
Connection Strength
2.753
-
Time to Personalize Surveillance for Cancer Therapy-Related Cardiac Dysfunction in HER2-Targeted Therapy: One Size Does Not Fit All. Curr Heart Fail Rep. 2026 Jul 22; 23(1).
Score: 0.959
-
Early anthracycline cardiotoxicity in adolescents and young adults with sarcoma: a prospective echocardiographic study. ESC Heart Fail. 2026 May 05; 13(3).
Score: 0.236
-
Standardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology Providers. Cancer Med. 2026 Apr; 15(4):e71682.
Score: 0.235
-
Radiation Doses to Cardiac Substructures Predict Elevation in High-sensitivity Cardiac Troponin T Levels in Radiation Therapy for Lung Cancer. Int J Radiat Oncol Biol Phys. 2026 Mar 15; 124(4):1124-1136.
Score: 0.228
-
Cardiovascular toxicity of immune therapies for cancer. BMJ. 2024 05 15; 385:e075859.
Score: 0.206
-
Myocardial Dysfunction in Patients with Cancer. Heart Fail Clin. 2022 Jul; 18(3):361-374.
Score: 0.181
-
Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils. J Natl Cancer Inst. 2021 05 04; 113(5):513-522.
Score: 0.167
-
Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment. J Am Heart Assoc. 2020 01 21; 9(2):e013757.
Score: 0.153
-
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association. J Clin Oncol. 2026 Aug; 44(22):2140-2155.
Score: 0.060
-
Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology. Eur J Heart Fail. 2025 Nov; 27(11):2152-2167.
Score: 0.057
-
Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America. J Card Fail. 2025 02; 31(2):415-455.
Score: 0.053
-
Circulating microRNAs and Cytokines as Prognostic Biomarkers for Doxorubicin-Induced Cardiac Injury and for Evaluating the Effectiveness of an Exercise Intervention. Clin Cancer Res. 2023 11 01; 29(21):4430-4440.
Score: 0.050
-
Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment. Curr Oncol Rep. 2022 05; 24(5):543-553.
Score: 0.044
-
Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience. Open Heart. 2021 12; 8(2).
Score: 0.043
-
Cardiovascular Toxicities of Androgen Deprivation Therapy. Curr Treat Options Oncol. 2021 04 17; 22(6):47.
Score: 0.042
-
Modern Radiotherapy and Risk of Cardiotoxicity. Chemotherapy. 2020; 65(3-4):65-76.
Score: 0.040